Select Funding Opportunities

All entries below for external and internal funding opportunities were provided by the USF Health Morsani College of Medicine Office of Research:

NIH FUNDING 

Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed) (PA-19-065)
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) (PAR-19-204)
National Human Genome Research Institute
National Institute of Mental Health
Application Receipt/Submission Date(s): May 20, 2019; May 18, 2020; May 20, 2021, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) (PAR-19-193)
National Cancer Institute
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) (PAR-19-194)
National Cancer Institute
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 16, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) (RFA-CA-19-019)
National Cancer Institute
Application Receipt Date(s): May 28, 2019; Sept. 27, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) (PAR-19-149)
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) (PAR-19-150)
National Cancer Institute
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) (PAS-19-105)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
National Institute on Aging
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 5, 2019.

Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) (PA-19-077)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 5, 2019.

EXTERNAL FUNDING 

Pediatric Research Grants
Gerber Foundation
Application Receipt/Submission Date(s): Concept Paper due May 15, 2019. Full proposal due Aug. 15, 2019.

Medical Research Program
W.M. Keck Foundation
Application Receipt/Submission Date(s): May 1, 2019

OTHER RESOURCES:  

Find NIH Grants: Search Active Grants http://grants.nih.gov/grants/guide/index.html

Weekly Grant ListServ:  http://grants.nih.gov/grants/guide/listserv.htm

Find Other Federal Funding:
National Science Foundation:  http://www.nsf.gov/funding/
Congressionally Directed Medical Research Program: http://cdmrp.army.mil/

Find Grants.gov website at:  https://www.grants.gov/

Find Restricted Awards: –Limited subs-must be USF DSR pre-reviewed http://www.research.usf.edu/limited-submissions/usfri-limited-submissions.asp

Find USF Sources List: Medicine: http://health.usf.edu/medicine/research/~/media/21BA8C9B0E40452695D62FEE8A08273F.ashx

Find Some External Agency Links: http://health.usf.edu/medicine/research/funding_oppt